A £42m project called ‘Transformation’ has been launched with the aim of developing effective and low-risk methods for the early detection of prostate cancer in British men. The project, which is supported by the British Prostate Cancer Institute, the National Institute for Health and Care Research (NIHR) and other partners, seeks to find a solution to one of the most important men’s health challenges in the UK.
According to Tekna Technology Media Medical and Health News Service, prostate cancer is one of the most common cancers among British men and kills thousands of people every year. Despite this, there is no accurate screening method for early diagnosis of this disease. Often times, prostate cancer symptoms appear in advanced stages and when it is more difficult to treat.
The main goal of the project “Transformation” is to find the best way to screen the British male population and detect prostate cancer in its early stages. The researchers hope that by implementing this project, they will be able to find a method that has both high accuracy and few side effects for patients.
The prostate is a gland found only in men and plays an important role in the reproductive system. Prostate cancer occurs when the cells of this gland grow abnormally. In the early stages, the disease may be asymptomatic. Currently, one of the prostate cancer diagnosis methods is measuring the level of prostate specific antigen (PSA) in the blood. However, this method alone is not enough to definitively diagnose cancer, as an increase in PSA levels may also have other causes. In addition, prostate biopsy, which is performed to definitively diagnose cancer, is an invasive procedure and may have complications such as infection.
For this reason, the British National Screening Committee has so far refused to implement a widespread screening program for prostate cancer. However, the researchers of the “Tavahal” project hope to find a method that can be used as a gold standard for early diagnosis of this disease by conducting detailed and extensive studies. With the success of this project, it is hoped that in the near future, British men will be able to screen prostate cancer with greater confidence and, if they are diagnosed with this disease, be diagnosed at an early and treatable stage.
To see the latest news, refer to the scientific news page of Tekna Media
RCO NEWS